Pfizer CEO Albert Bourla Buys 79 Phantom Shares, Signaling Confidence in Company’s Pipeline—No Market Shock Expected
Albert Bourla’s recent phantom‑stock purchase shows steady confidence in Pfizer’s pipeline and long‑term value creation.
3 minutes to read